External Quality Control of ER, PR, and HER2 Immunohistochemistry and Continued Need for Optimization
13 Dec 2012

Breast pathology routinely employs immunohistochemistry for the classification and subsequent selection of patients for specific therapies. However, correct interpretation, is dependent on the quality of the staining produced, which can vary enormously between laboratories, and in some instanced show day-to-day variation within the same laboratory. Therefore, it is vital that laboratories not only use standardized staining procedures for ER,PR and HER2 immunohistochemistry but also optimize protocols as required.

Leica Microsystems



Show    per page
1 of 9 Page     1 2 3  ... Next 
Light Sheet Imaging for Fast 3D Live Cell and Tissue Imaging26 Feb 2015Read
A New Approach for Color Quality Control in Whole Slide Imaging Systems12 Feb 2015Read
Strategies for the Separation and Characterization of Protein Biopharmaceuticals28 Jan 2015Read
Simultaneous Quantitative Determination and Screening of Pesticides in Fruits and Vegetables using LC-Q-Orbitrap-MS10 Dec 2014Read
Nanoparticle size characterization: Tips and Tricks8 Dec 2014Read
Sprint Bioscience on label-free fragment screening8 Dec 2014Read
Imaging Masterclass 3: Static vs. Dynamic Image Analysis8 Dec 2014Read
Laser Diffraction Masterclass 58 Dec 2014Read
How to characterize and optimize inkjet inks Part 38 Dec 2014Read
Exploring OMICS in 3D Microtissues4 Dec 2014Read